Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
报名条件(概要)
- 年龄:18 Years – 不限
- 性别:不限
- 健康志愿者:接受
完整入排标准请以官方页面为准。
开展国家/地区
China
研究药物 / 干预措施
Recombinant Respiratory Syncytial Virus Vaccine(CHO cell)(Adjuvanted)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Blank adjuvant)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Adjuvanted)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant)
申办方
Ab&B Bio-tech Co., Ltd.JS
研究简介(原文)
The primary objective of the phase I trial is to evaluate the safety and tolerability of different doses of the recombinant respiratory syncytial virus vaccine (CHO cell) (Adjuvanted) in adults aged 18 years and older, with the secondary objective being to assess its immunogenicity. The primary objectives of the phase II trial are to evaluate the immunogenicity and safety of the recombinant respiratory syncytial virus vaccine (CHO cell) (Adjuvanted) with different adjuvant ratios in adults aged 60 years and older, with the secondary objective being to evaluate the persistence of immune responses.
适应症
主动联系研究团队
总联系人(申办方/研究总部)
- Xue Zhao, Masterzhaoxue@abbbio.com.cn18168168075
中国/港澳台研究中心
- Zigong Center for Disease Control and PreventionZigong,Sichuan,China
问自己是否符合条件、如何预筛
我的病情档案
档案只保存在您自己的浏览器里,不会上传,任何人(包括本站)都看不到。
英文版(发给研究团队)
Dear Study Team, I am a patient in China and I am interested in participating in your clinical trial: Study Title: Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. ClinicalTrials.gov Identifier: NCT07582796 Sponsor: Ab&B Bio-tech Co., Ltd.JS Investigational product: Recombinant Respiratory Syncytial Virus Vaccine(CHO cell)(Adjuvanted), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Blank adjuvant), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Adjuvanted), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant) About me: - Age: (please fill in) - Sex: (please fill in) - Confirmed diagnosis and stage: (please fill in) - Biomarkers / genetic testing: not available - Prior and current treatments: (please fill in) - Performance status (ECOG): not assessed - Current location: China - Travel ability: (please fill in) Could you please let me know: 1. Whether I might be eligible for this study; 2. Which site would be closest and most practical for me, and whether remote pre-screening is possible; 3. What documents (medical records, pathology or imaging reports, recent labs) I should prepare for pre-screening. I can provide English translations of my medical records. Thank you very much for your time and help. Kind regards, (your name) (your email / phone with country code)
中文对照(供您核对)
尊敬的研究团队: 我是一位来自中国的患者,希望咨询参加以下临床试验的可能: 研究名称:Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. 试验编号:NCT07582796 申办方:Ab&B Bio-tech Co., Ltd.JS 研究药物:Recombinant Respiratory Syncytial Virus Vaccine(CHO cell)(Adjuvanted)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Blank adjuvant)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Adjuvanted)、Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant) 我的基本情况: - 年龄:(请填写) - 性别:(请填写) - 确诊疾病与分期:(请填写) - 基因/标志物检测:暂无 - 既往及当前治疗:(请填写) - 体能状态(ECOG):未评估 - 目前所在城市:中国 - 可前往范围:(请填写) 想请教三个问题: 1. 我是否可能符合本研究的入组标准? 2. 哪个中心对我最方便可行?能否远程预筛? 3. 预筛需要准备哪些资料(病历、病理、影像、近期化验)? 我可以提供英文翻译版病历。感谢您的时间与帮助。 顺祝安康 (您的姓名) (您的邮箱/带国际区号的电话)
提示:请与主治医生一起发信——由医生署名的申请,回复率远高于患者单独发信。首封邮件不要附身份证号等敏感信息。研究团队通常在 3–10 个工作日内回复,两周无回音可礼貌追问一次。
下一步怎么做?
- 把本页信息带给您的主治医生,评估是否适合参加。
- 点击下方按钮打开官方注册页,查看研究中心联系方式。
- 直接联系研究团队咨询报名事宜(通常有中文同声翻译服务可协助沟通)。